Article
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase…
medRxiv · 2022 · Iyer, S. R.; Nusser, K.; Jones, K.; Shinde, P.; Beach, C. Z.; Keddy, C.; Aguero, E.; Force, J.; Shinde, U.; Davare, M. A.
Key facts
| Title | Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors |
|---|---|
| First author | Iyer, S. R.; Nusser, K.; Jones, K.; Shinde, P.; Beach, C. Z.; Keddy, C.; Aguero, E.; Force, J.; Shinde, U.; Davare, M. A. |
| Journal | medRxiv |
| Published | Dec 27, 2022 |
| DOI | 10.1101/2022.12.27.521482 |
| Devices mentioned | K800781, K810863 |
| Product codes mentioned | DBM, KIS, NQF |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1